The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...
Windtree Therapeutics, Inc. (NasdaqCM: WINT) showcased encouraging results from the Phase 2b SEISMiC study of istaroxime, its novel investigational therapy for early cardiogenic shock, at the ...